Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) is a Brazil-focused medical education group and medical practice solutions provider whose news flow reflects developments across education, healthcare and capital markets. The company describes itself as a leading medical education group in Brazil based on the number of medical school seats, operating an end‑to‑end physician‑centric ecosystem that spans undergraduate education, continuing medical education and digital tools that support medical practice.
News about Afya often covers its quarterly and interim financial results, where the company reports performance for its three segments: Undergraduate, Continuing Education and Medical Practice Solutions. These updates include information on revenue, adjusted EBITDA, net income and key operational drivers such as approved medical school seats, total students, active payers and users positively impacted by its ecosystem.
Investors following AFYA news will also see announcements related to regulatory and academic milestones in Brazil, such as authorizations from the Ministry of Education (MEC) to increase medical school seats at specific campuses. These decisions affect Afya’s capacity in its Undergraduate segment and are highlighted as important growth drivers in the company’s communications.
Corporate and capital structure events are another recurring theme. Afya has issued commercial notes through its subsidiary Afya Participações S.A., repaid debentures, and entered into agreements to repurchase and cancel Series A perpetual convertible preferred shares previously issued to an affiliate of SoftBank. The board of directors has also approved share repurchase programs for Class A common shares, and the company has reported changes to its board composition and independent registered public accounting firm.
This news page aggregates these types of updates so readers can track AFYA’s financial performance, governance decisions, regulatory developments in medical education and initiatives within its medical practice solutions segment. For investors and observers of Brazil’s education and healthcare sectors, Afya’s news provides ongoing insight into how the company manages its physician‑centric ecosystem and capital structure.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education group in Brazil, announced the resignation of Mrs. Shobhna Mohn from its Board of Directors, effective June 30, 2024. Mohn's departure is unrelated to Afya’s operations or practices. During her tenure, she contributed significantly to Afya's growth, supporting its journey to becoming a top medical education and practice solutions provider in Brazil. Afya highlighted her strategic insights and leadership as pivotal to its success. The company has no immediate plans to fill her position. The board remains committed to strong governance with diverse skills and experience.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education and practice solutions provider in Brazil, announced the successful passage of a key resolution at its Annual General Meeting on June 5, 2024. Shareholders approved and ratified the company's financial statements and the auditor’s report for the fiscal year ending December 31, 2023.
Afya has announced its Annual General Meeting (AGM) scheduled for June 5, 2024, at 10:00 a.m. BRT. The meeting will take place at their Nova Lima office and virtually through a provided link. The main agenda item is the approval and ratification of the company's financial statements and the auditor's report for the fiscal year ending December 31, 2023. The record date for shareholders eligible to attend is May 10, 2024. The company encourages shareholders to participate and vote, either in person or via proxy. The company's financial statements are available on their investor relations website.
Afya reported solid financial results for the first quarter of 2024, with a 13.3% increase in net revenue to R$804.2 million and a 20.5% growth in adjusted EBITDA to R$397.9 million, leading to an adjusted EBITDA margin expansion of 300 bps. The company also saw significant increases in net income and adjusted net income. Afya's ecosystem reached 334,368 users, reflecting its strong presence in the medical education and practice solutions market in Brazil. The company reaffirmed its guidance for 2024, aiming for continued growth and acquisitions to enhance its offerings.
Afya has announced the acquisition of Unidompedro and Faculdade Dom Luiz, adding 300 medical school seats in Brazil. The purchase price is R$660.0 million, with payment split between cash and installments. The transaction is subject to regulatory approval.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.